Tools for higher-order OCT assessment enable evaluation of features of interest, such as targeted retinal layers or fluid compartments, and may allow for unique characterization of disease phenotypes and treatment response.
Study shows routine use may improve patient management, guide procedure planning
Optical coherence tomography angiography (OCTA) may be as an important tool in the management of patients with glaucoma, according to Robert L. Stamper, MD.
Researchers seeking fluid features, retinal integrity measures to test next step in image analysis and image interrogation in clinical trials.
Imaging provides ophthalmologists with additional valuable information
With imaging artifacts common, clinicians must be focused on key points
Technology makes great tool, requires extra vigilance with co-existing disease
Common devices differ in hardware, analysis, and display of data
Optical coherence tomography angiography (OCTA) was introduced commercially in 2015,1 and it ushered in a different way of viewing retinal and choroidal vasculature.
Robert L. Stamper, MD, discusses the current state of OCT angiography, and what remains on the horizon for glaucoma care.